Oura Expands Healthcare Capabilities with $625 Million Acquisition of Counsel Health

Smart ring manufacturer and health intelligence platform Oura has agreed to purchase artificial intelligence health company Counsel Health for $625 million. The transaction, announced in a corporate release, follows Oura decision to delay its initial public offering despite previously reporting strong demand from investors.

Combining Biometric Data With Clinical Expertise

Counsel Health was established by a team of physicians and artificial intelligence researchers. The company integrates medical artificial intelligence capabilities with internal medical professionals to offer rapid clinical guidance and patient care. Under the terms of the transaction, Oura intends to merge its continuous biometric tracking data with the Counsel platform to give users access to on-demand human physicians.

Company executives indicated that users will be able to transition seamlessly from reviewing biometric insights to communicating directly with Counsel medical artificial intelligence for tailored health recommendations. When necessary, these digital conversations can be escalated to board-certified physicians within minutes.

Strategic Shifts Following IPO Postponement

The acquisition arrives just weeks after Oura chose to put its public market debut on hold, pointing to broader market volatility. Although the initial public offering had been planned for late September, Chief Executive Officer Tom Hale stated that the organization maintains the flexibility to select a more optimal window for going public.

• Oura acquired Counsel Health for $625 million in a deal announced in November.
• The acquisition follows the postponement of Oura initial public offering due to market uncertainty.
• The integration will allow users to connect biometric data directly with medical artificial intelligence and physicians.

By integrating Counsel Health into its ecosystem, Oura aims to provide continuous healthcare support ranging from routine inquiries and prescription management to chronic condition oversight and medical referrals. Hale described the initiative as a significant milestone in establishing an accessible model for proactive healthcare delivery.